Table VII.
Best-evidence synthesis and recommendations
| PROM | Content validity | Structural validity | Internal consistency | Reliability | Measurement error | Construct validity | Measurement invariance | Responsiveness | Recommendation |
|---|---|---|---|---|---|---|---|---|---|
| ACSDQ | W | ??? | B | ||||||
| CDLQI | W | W | + | B | |||||
| CDLQI-C | W | ? | W | W | B | ||||
| CQI-CSD | W | W | W | W | B | ||||
| DIS | W | ? | B | ||||||
| DLQI | W | ??? | +++ | ? | +++ | +++ | B | ||
| DLQI-B | W | ++ | B | ||||||
| DLQI-C | +++ | +++ | +++ | W | B | ||||
| DLQI-D | W | W | ??? | B | |||||
| DLQI-I | +++ | +++ | +++ | B | |||||
| DLQI-N | ?? | ++ | ++ | B | |||||
| DLQI-S | --- | W | + | C | |||||
| DLQI-T | ? | W | B | ||||||
| DLQI-U | W | B | |||||||
| DQOLs | W | ?? | W | + | – | B | |||
| DSQL | W | ??? | +++ | + | +++ | +++ | B | ||
| FLQA-d | W | +++ | ? | +++ | +++ | B | |||
| PBI | ± | ? | ? | ++ | B | ||||
| PeDeSI | W | ?? | ++ | B | |||||
| PRISM | +++ | + | B | ||||||
| SF-QES | W | --- | ++ | C | |||||
| Skindex | W | ??? | W | W | – | W | B | ||
| S29 | W | ??? | +++ | W | +++ | W | B | ||
| S29-C | W | -- | W | +++ | B | ||||
| S29-G | ??? | +++ | +++ | W | B | ||||
| S29-S | W | +++ | – | --- | C | ||||
| S29-Sp | --- | +++ | W | +++ | W | C | |||
| S16 | W | ++ | ++ | + | W | B | |||
| S16-A | +++ | ++ | B | ||||||
| S16-BP | +++ | W | +++ | B | |||||
| S16-C | W | --- | W | +++ | C | ||||
| S16-J | +++ | +++ | B | ||||||
| S16-M | W | +++ | + | +++ | B | ||||
| S16-U | ++ | B | |||||||
| TQL | ± | ?? | ++ | W | ++ | B | |||
| VQ-Dermato | W | ?? | -- | ? | +++ | ++ | B |
PROM: patient-reported outcome measures; ACSD: Adjustment to Chronic Skin Diseases Questionnaire; CDLQI: Children’s Dermatology Life Quality Index; CDLQI-C: CDLQI Cantonese; CQI-CSD: Consumer Quality Index Chronic Skin Disease; DIS: Dermatology Intimacy Scale; DLQI: Dermatology Life Quality Index; DLQI-B: DLQI Brazilian-Portuguese; DLQI-C: DLQI Chinese; DLQI-D: DLQI Danish; DLQI-I: DLQI Italian; DLQI-N: DLQI Norwegian; DLQI-S: DLQI Sinhala; DLQI-T: DLQI Turkish; DLQI-U: DLQI Ukrainian; DQOLs: Dermatology Quality of Life scales; DSQL: Dermatology-specific Quality of Life; FLQA-d: Freiburg Life Quality Assessment; PBI: Patient Benefit Index; PeDeSI: Person-Centred Dermatology Self-Care Index; PRISM: Pictorial Representation of Illness & Self-Measure; SF-QES: Short-form of the Questionnaire on Experience with Skin Complaints; S29: Skindex 29; S29-C: S29-Chinese; S29-G: S29-German; S29-S: S29-Serbian; S29-Sp: S29-Spanish; S16: Skindex-16; S16-A: S16-Arabic; S16-BP: S16-Brazilian-Portuguese; S16-C: S16-Chinese; S16-J: S16-Japanese; S16-M: S16-Moroccan-Arabic; S16-U: S16-Ukrainian; TQL: Turkish Quality of Life Instrument for skin disease; +++: High-quality evidence for a sufficient measurement property. ---: High-quality evidence for an insufficient measurement property. ???: High-quality evidence for an indeterminate measurement property. ++: Moderate evidence for a sufficient measurement property. --: Moderate evidence for an insufficient measurement property. ??: Moderate evidence for an indeterminate measurement property. +: Low-quality evidence for a sufficient measurement property. –: Low-quality evidence for an insufficient measurement property. ?: Low-quality evidence for an indeterminate measurement property. W: Very low evidence for a measurement property. ±: Conflicting evidence for a measurement property.